Announcements Trials
Browse Landscape

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Head & Neck 4Thoracic 2Other hematologic neoplasm 2Myeloid 2Gynecologic 2CNS 2Tumor-Agnostic 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Vulvar Neoplasms 1Thyroid Neoplasms 1Teratoma, Ovarian 1Struma Ovarii 1Ovarian Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 527Cisplatin 355Bevacizumab 256pembrolizumab 226Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 126Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 90niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 73Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 56Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
DNA × Gynecologic × Clear all
NCT04053114 2025-08-29

MOLTHYSO

Institut Bergonié

Withdrawn
GynecologicHead & Neck

Teratoma, Ovarian, Ovarian Neoplasms, Struma Ovarii, Thyroid Neoplasms

NCT06582108 2024-09-03

ROAR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting
190 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡